Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2614

1.

Association of aberrant neural synchrony and altered GAD67 expression following exposure to maternal immune activation, a risk factor for schizophrenia.

Dickerson DD, Overeem KA, Wolff AR, Williams JM, Abraham WC, Bilkey DK.

Transl Psychiatry. 2014 Jul 29;4:e418. doi: 10.1038/tp.2014.64.

PMID:
25072323
[PubMed - as supplied by publisher]
2.

[NMDA-type glutamate receptor and schizophrenia].

Nishikawa T, Ishiwata S.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Nov;33(5-6):217-24. Japanese.

PMID:
25069261
[PubMed - in process]
3.

[Perinatal innate immune activation and neuropsychological development].

Nagai T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2013 Aug;33(4):149-54. Japanese.

PMID:
25069250
[PubMed - in process]
4.

Genetic Dys-regulation of Astrocytic Glutamate Transporter EAAT2 and its Implications in Neurological Disorders and Manganese Toxicity.

Karki P, Smith K, Johnson J Jr, Aschner M, Lee EY.

Neurochem Res. 2014 Jul 27. [Epub ahead of print]

PMID:
25064045
[PubMed - as supplied by publisher]
5.

Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Orlando R, Borro M, Motolese M, Molinaro G, Scaccianoce S, Caruso A, di Nuzzo L, Caraci F, Matrisciano F, Pittaluga A, Mairesse J, Simmaco M, Nisticò R, Monn JA, Nicoletti F.

Neuropharmacology. 2014 Jul 22. pii: S0028-3908(14)00271-8. doi: 10.1016/j.neuropharm.2014.07.009. [Epub ahead of print]

PMID:
25063582
[PubMed - as supplied by publisher]
6.

Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.

Wesseling H, Guest PC, Lee CM, Wong EH, Rahmoune H, Bahn S.

Mol Autism. 2014 Jul 4;5:38. doi: 10.1186/2040-2392-5-38. eCollection 2014.

PMID:
25061506
[PubMed]
Free PMC Article
7.

New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.

Perez SM, Lodge DJ.

Drug Des Devel Ther. 2014 Jul 2;8:887-896. eCollection 2014. Review.

PMID:
25061280
[PubMed - as supplied by publisher]
Free PMC Article
8.

A Role for Picomolar Concentrations of Pregnenolone Sulfate in Synaptic Activity-dependent Ca2+ signaling and CREB Activation.

Smith C, Martin SC, Sugunan K, Russek SJ, Gibbs TT, Farb DH.

Mol Pharmacol. 2014 Jul 23. pii: mol.114.094128. [Epub ahead of print]

PMID:
25057049
[PubMed - as supplied by publisher]
Free Article
9.

The role of F-actin in modulating Clathrin-mediated endocytosis: Lessons from neurons in health and neuropsychiatric disorder.

Loebrich S.

Commun Integr Biol. 2014 Apr 3;7:e28740. doi: 10.4161/cib.28740. eCollection 2014. Review.

PMID:
25053985
[PubMed]
Free PMC Article
10.

Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia.

Kraguljac NV, White DM, Hadley J, Reid MA, Lahti AC.

Hippocampus. 2014 Jul 17. doi: 10.1002/hipo.22332. [Epub ahead of print]

PMID:
25045047
[PubMed - as supplied by publisher]
11.

Developmental exposure to the organochlorine insecticide endosulfan alters expression of proteins associated with neurotransmission in the frontal cortex.

Wilson WW, Onyenwe W, Bradner JM, Nennig SE, Caudle WM.

Synapse. 2014 Jul 17. doi: 10.1002/syn.21764. [Epub ahead of print]

PMID:
25042905
[PubMed - as supplied by publisher]
12.

Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor.

Cid JM, Tresadern G, Duvey G, Lütjens R, Finn T, Rocher JP, Poli S, Vega JA, de Lucas AI, Matesanz E, Linares ML, Andrés JI, Alcazar J, Alonso JM, Macdonald GJ, Oehlrich D, Lavreysen H, Ahnaou A, Drinkenburg W, Mackie C, Pype S, Gallacher D, Trabanco AA.

J Med Chem. 2014 Jul 28. [Epub ahead of print]

PMID:
25032784
[PubMed - as supplied by publisher]
13.

Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulator.

Pollard M, Bartolome JM, Conn PJ, Steckler T, Shaban H.

J Psychopharmacol. 2014 Jul 16. pii: 0269881114542856. [Epub ahead of print]

PMID:
25031220
[PubMed - as supplied by publisher]
14.

Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia.

Iasevoli F, Buonaguro EF, Sarappa C, Marmo F, Latte G, Rossi R, Eramo A, Tomasetti C, de Bartolomeis A.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 12;54C:299-314. doi: 10.1016/j.pnpbp.2014.07.003. [Epub ahead of print]

PMID:
25025505
[PubMed - as supplied by publisher]
15.

The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies.

Wierońska JM, Sławińska A, Lasoń-Tyburkiewicz M, Gruca P, Papp M, Zorn SH, Doller D, Kłeczek N, Noworyta-Sokołowska K, Gołembiowska K, Pilc A.

Psychopharmacology (Berl). 2014 Jul 11. [Epub ahead of print]

PMID:
25012236
[PubMed - as supplied by publisher]
16.

A Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of a Metabotropic Glutamate 2/3 Receptor Agonist Using an Electronic Patient-Reported Outcome Device in Patients With Schizophrenia.

Stauffer VL, Baygani SK, Kinon BJ, Krikke-Workel JO.

J Clin Psychopharmacol. 2014 Jul 8. [Epub ahead of print]

PMID:
25006819
[PubMed - as supplied by publisher]
17.

Quantitative analyses of schizophrenia-associated metabolites in serum: serum d-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.

Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T.

PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.

PMID:
25004141
[PubMed - in process]
Free PMC Article
18.

The Glutamate Hypothesis: A Pathogenic Pathway from which Pharmacological Interventions have Emerged.

Veerman SR, Schulte PF, de Haan L.

Pharmacopsychiatry. 2014 Jul;47(4-5):121-30. doi: 10.1055/s-0034-1383657. Epub 2014 Jul 7.

PMID:
25002292
[PubMed - in process]
19.

Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis.

Veerman SR, Schulte PF, Begemann MJ, Engelsbel F, de Haan L.

Pharmacopsychiatry. 2014 Jul 7. [Epub ahead of print]

PMID:
25002291
[PubMed - as supplied by publisher]
20.

Glutamate receptors of the delta family are widely expressed in the adult brain.

Hepp R, Audrey Hay Y, Aguado C, Lujan R, Dauphinot L, Potier MC, Nomura S, Poirel O, El Mestikawy S, Lambolez B, Tricoire L.

Brain Struct Funct. 2014 Jul 8. [Epub ahead of print]

PMID:
25001082
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk